Cargando…
Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
BACKGROUND: Cardiovascular disease is the leading cause of mortality and morbidity worldwide, Chronic stable angina (CSA) is the main symptom of myocardial ischemia, causes increased risk of major cardiovascular events such as sudden cardiac death and myocardial infarction. Naoxintong (NXT) capsule...
Autores principales: | Huanjia, Gao, Hairong, Cai, Jieqin, Zhuang, Xingzhen, Dai, Xue, Fu, Weizhang, Zhang, Bojun, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112004/ https://www.ncbi.nlm.nih.gov/pubmed/33971940 http://dx.doi.org/10.1186/s13063-021-05264-y |
Ejemplares similares
-
Efficacy and safety of Guhong injection for treating coronary microvascular disease: study protocol for a randomized controlled trial
por: Jieqin, Zhuang, et al.
Publicado: (2020) -
A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021) -
Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial
por: Wang, Yu, et al.
Publicado: (2022) -
Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial
por: Zhao, Shuai, et al.
Publicado: (2018) -
Specific DNA identification of Pheretima in the Naoxintong capsule
por: Zhu, Xiaoxiao, et al.
Publicado: (2019)